|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 8/29/17 Hemispherx Biopharma Inc 8-K:5,8,9 8/22/17 4:76K M2 Compliance/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 18K 2: EX-10.1 Material Contract HTML 12K 3: EX-10.2 Material Contract HTML 8K 4: EX-10.3 Material Contract HTML 8K
Exhibit 10.2
Memo
| Date: | August 25, 2017 | |
| To: | ||
| From: | Ann Marie Coverly | |
| Re: | 40% Pay Deferral |
This memo is to acknowledge your understanding of and agreement to terms conveyed to you in recent conversations regarding the deferral of 40% of your pay commencing for the first pay period in September 2017 and continuing until discontinued by the Board of Directors.
In order to conserve cash upper management has agreed to a pay deferral of 40%. You hereby authorize the Company to withhold 40% of your salary on a per pay period basis. The deferred compensation will be paid to these Executives, minus appropriate withholdings at such time as the Board Determines.
As an incentive for deferring compensation, you will be awarded common stock purchase options with an exercise price of $0.37 per shares, the closing price of the Common Stock on the NYSE American on August 25, 2017, the number and other terms of which will be determined at a later date by and in the discretion of the Board.
I hereby acknowledge my understanding of and agree to the above:
| Date | ||||
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 8/29/17 | None on these Dates | ||
| Filed on: | 8/28/17 | |||
| 8/25/17 | ||||
| For Period End: | 8/22/17 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/19/24 AIM ImmunoTech Inc. S-1 6:628K M2 Compliance LLC/FA 4/01/24 AIM ImmunoTech Inc. 10-K 12/31/23 84:8.7M M2 Compliance LLC/FA 3/31/23 AIM ImmunoTech Inc. 10-K 12/31/22 87:8.7M M2 Compliance LLC/FA 8/15/22 AIM ImmunoTech Inc. 10-Q 6/30/22 72:6M M2 Compliance LLC/FA 5/13/22 AIM ImmunoTech Inc. 10-Q 3/31/22 68:5.6M M2 Compliance LLC/FA 3/31/22 AIM ImmunoTech Inc. 10-K 12/31/21 90:9.3M M2 Compliance LLC/FA 3/31/21 AIM ImmunoTech Inc. 10-K 12/31/20 94:7.6M M2 Compliance LLC/FA |